Real-time image processing for label-free enrichment of Actinobacteria cultivated in picolitre droplets†
Abstract
The majority of today's antimicrobial therapeutics is derived from
Maintenance work is planned from 09:00 BST to 12:00 BST on Saturday 28th September 2024.
During this time the performance of our website may be affected - searches may run slowly, some pages may be temporarily unavailable, and you may be unable to access content. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
Bio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany
E-mail:
martin.roth@hki-jena.de
b
Applied Systems Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany
E-mail:
thilo.figge@hki-jena.de
c German Rheumatism Research Centre (DRFZ), Berlin, Germany
d Nanobiophotonics, Institute of Photonic Technology (IPHT), Jena, Germany
e Friedrich Schiller University, Jena, Germany
The majority of today's antimicrobial therapeutics is derived from
E. Zang, S. Brandes, M. Tovar, K. Martin, F. Mech, P. Horbert, T. Henkel, M. T. Figge and M. Roth, Lab Chip, 2013, 13, 3707 DOI: 10.1039/C3LC50572C
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content